Cell therapy CMC and quality control

CELL AND GENE THERAPY INSIGHTS

May 2021

Cell therapy CMC and quality control

Download PDF

Foreword

Cell therapy CMC and quality control

Cell therapy CMC and quality control

Christiane Niederlaender

Research Article

Characterization of a novel high-throughput, high-speed and high-precision plate-based image cytometric cell counting method

Characterization of a novel high-throughput, high-speed and high-precision plate-based image cytometric cell counting method

J Bell, Y Huang, H Qazi et al.

Expert Insight

The role of big data analytics in digitized manufacturing

The role of big data analytics in digitized manufacturing

Damian Marshall, John Churchwell, Marc-Olivier Baradez

Addressing sampling challenges in early phase cell therapy manufacturing

Addressing sampling challenges in early phase cell therapy manufacturing

Stephanie Mgebroff

Expert Roundtable Video

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

26 September 2021

Expert Roundtable

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Expert Roundtable: analytical tools for cell and gene therapy: what’s new and what’s next?

Sarah Snykers, Andrea Moore, Tony Bou Kheir

25 September 2021

Commentary

Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

Outcomes from a cell viability workshop: fit-for-purpose considerations for cell viability measurements for cellular therapeutic products

L Pierce, S Sarkar, L Li-Ying Chan et al.

Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

Finding quality in complexity: how cellular therapeutics are shifting analytical paradigms for clinical supply and product manufacturing

Vilma Jimenez Sabinina, Dominic Günter Hildebrand

Interview

Bioprocess and analytics priorities for the tissue engineered product and cell therapy fields

Bioprocess and analytics priorities for the tissue engineered product and cell therapy fields

Julie Allickson, PhD

Unleashing the full power of next gen bioanalytics on cell therapy development

Unleashing the full power of next gen bioanalytics on cell therapy development

Eric Alonzo, PhD